Hera Women's Health shares results from PRIME trial led by Brian K. Iriye, MD showing biomarker-guided care reduces NICU use.
Hera Women's Health is featuring findings from the PRIME multicenter randomized controlled trial supported by Sera Prognostics, Inc. Dr. Brian K. Iriye from Hera Women's Health led the study as the Primary Investigator and main author. The study took place in Las Vegas and the results were published on January 7, 2026.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments